- Home
- EEA vs CBUS Comparison
EEA vs CBUS Comparison
Compare EEA & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- CBUS
- Stock Information
- Founded
- EEA 1986
- CBUS 2010
- Country
- EEA Germany
- CBUS United States
- Employees
- EEA N/A
- CBUS N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- CBUS Agricultural Chemicals
- Sector
- EEA Finance
- CBUS Industrials
- Exchange
- EEA Nasdaq
- CBUS Nasdaq
- Market Cap
- EEA 57.7M
- CBUS 65.3M
- IPO Year
- EEA N/A
- CBUS 2017
- Fundamental
- Price
- EEA $9.66
- CBUS $2.15
- Analyst Decision
- EEA
- CBUS Strong Buy
- Analyst Count
- EEA 0
- CBUS 3
- Target Price
- EEA N/A
- CBUS $22.17
- AVG Volume (30 Days)
- EEA 9.2K
- CBUS 131.5K
- Earning Date
- EEA 01-01-0001
- CBUS 05-08-2025
- Dividend Yield
- EEA 1.92%
- CBUS N/A
- EPS Growth
- EEA N/A
- CBUS N/A
- EPS
- EEA N/A
- CBUS N/A
- Revenue
- EEA N/A
- CBUS $4,751,000.00
- Revenue This Year
- EEA N/A
- CBUS $105.58
- Revenue Next Year
- EEA N/A
- CBUS $194.76
- P/E Ratio
- EEA N/A
- CBUS N/A
- Revenue Growth
- EEA N/A
- CBUS 104.78
- 52 Week Low
- EEA $7.45
- CBUS $1.40
- 52 Week High
- EEA $9.26
- CBUS $19.56
- Technical
- Relative Strength Index (RSI)
- EEA 66.34
- CBUS 53.10
- Support Level
- EEA $9.53
- CBUS $1.96
- Resistance Level
- EEA $9.87
- CBUS $2.58
- Average True Range (ATR)
- EEA 0.15
- CBUS 0.25
- MACD
- EEA 0.04
- CBUS 0.04
- Stochastic Oscillator
- EEA 76.92
- CBUS 42.76
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.